{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-058532","form_type":"8-K","ticker":"PVLA","cik":"0001583648","company_name":"PALVELLA THERAPEUTICS, INC.","filed_at":"2025-06-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.879824+00:00","generated_at":"2026-05-19T13:13:22.991478+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Palvella shareholders elect Heron, Wessel as Class II directors; ratify EY","bullets":["Elaine J. Heron elected with 6,647,082 votes for, 1,255 withheld; Tadd S. Wessel with 6,487,034 for, 161,303 withheld.","Ratification of Ernst & Young as independent auditor for 2025: 7,299,907 for, 8,352 against, 7,334 abstain.","Advisory approval of 2024 named executive officer compensation: 6,550,393 for, 61,078 against, 36,866 abstain.","Broker non-votes on proposals 1 and 3 were 667,256."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-058532","json":"https://secwatch.observer/filing/0001104659-25-058532.json","markdown":"https://secwatch.observer/filing/0001104659-25-058532.md","text":"https://secwatch.observer/filing/0001104659-25-058532.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1583648/000110465925058532/0001104659-25-058532-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1583648/000110465925058532/tm2517565d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T13:13:22.991478+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}